Tieu Joanna, Shepherd Emily, Middleton Philippa, Crowther Caroline A
ARCH: Australian Research Centre for Health of Women and Babies, Robinson Research Institute, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, 1st floor, Queen Victoria Building, 72 King William Road, Adelaide, South Australia, Australia, 5006.
Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD010211. doi: 10.1002/14651858.CD010211.pub3.
Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for mothers and their infants both perinatally and long term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention in the interconception period to improve maternal and infant health outcomes.
To assess the effects of interconception care for women with a history of GDM on maternal and infant health outcomes.
We searched Cochrane Pregnancy and Childbirth's Trials Register (7 April 2017) and reference lists of retrieved studies.
Randomised controlled trials, including quasi-randomised controlled trials and cluster-randomised trials evaluating any protocol of interconception care with standard care or other forms of interconception care for women with a history of GDM on maternal and infant health outcomes.
Two review authors independently assessed study eligibility. In future updates of this review, at least two review authors will extract data and assess the risk of bias of included studies; the quality of the evidence will be assessed using the GRADE approach.
No eligible published trials were identified. We identified a completed randomised controlled trial that was designed to evaluate the effects of a diet and exercise intervention compared with standard care in women with a history of GDM, however to date, it has only published results on women who were pregnant at randomisation (and not women in the interconception period). We also identified an ongoing trial, in obese women with a history of GDM planning a subsequent pregnancy, which is assessing the effects of an intensive lifestyle intervention, supported with liraglutide treatment, compared with usual care. We also identified a trial that was designed to evaluate the effects of a weight loss and exercise intervention compared with lifestyle education also in obese women with a history of GDM planning a subsequent pregnancy, however it has not yet been published. These trials will be re-considered for inclusion in the next review update.
AUTHORS' CONCLUSIONS: The role of interconception care for women with a history of GDM remains unclear. Randomised controlled trials are required evaluating different forms and protocols of interconception care for these women on perinatal and long-term maternal and infant health outcomes, acceptability of such interventions and cost-effectiveness.
妊娠期糖尿病(GDM)与母亲及其婴儿在围产期和长期的不良健康结局相关。有GDM病史的女性在后续妊娠中有复发风险,在受孕间隔期进行干预可能有助于改善母婴健康结局。
评估针对有GDM病史女性的受孕间隔期护理对母婴健康结局的影响。
我们检索了Cochrane妊娠与分娩试验注册库(2017年4月7日)以及检索到的研究的参考文献列表。
随机对照试验,包括半随机对照试验和整群随机试验,评估任何针对有GDM病史女性的受孕间隔期护理方案与标准护理或其他形式的受孕间隔期护理对母婴健康结局的影响。
两位综述作者独立评估研究的纳入资格。在本综述的未来更新中,至少两位综述作者将提取数据并评估纳入研究的偏倚风险;将使用GRADE方法评估证据质量。
未检索到符合纳入标准的已发表试验。我们确定了一项已完成的随机对照试验,该试验旨在评估饮食和运动干预与标准护理相比,对有GDM病史女性的影响,然而迄今为止,它仅发表了随机分组时已怀孕女性(而非受孕间隔期女性)的结果。我们还确定了一项正在进行的试验,针对有GDM病史且计划再次怀孕的肥胖女性,该试验正在评估强化生活方式干预(辅以利拉鲁肽治疗)与常规护理相比的效果。我们还确定了一项试验,该试验旨在评估体重减轻和运动干预与生活方式教育相比,对同样是有GDM病史且计划再次怀孕的肥胖女性的影响,然而该试验尚未发表。这些试验将在下次综述更新时重新考虑是否纳入。
受孕间隔期护理对有GDM病史女性的作用仍不明确。需要进行随机对照试验,评估针对这些女性的不同形式和方案的受孕间隔期护理对围产期及母婴长期健康结局、此类干预措施的可接受性以及成本效益的影响。